Urologix, Inc.
ULGX · OTC
3/31/2015 | 12/31/2014 | 9/30/2014 | 6/30/2014 | |
|---|---|---|---|---|
| Market Cap | $1,660 | $1,527 | $2,243 | $3,727 |
| - Cash | $492 | $530 | $545 | $718 |
| + Debt | $5,332 | $5,333 | $5,333 | $5,333 |
| Enterprise Value | $6,500 | $6,330 | $7,031 | $8,342 |
| Revenue | $2,796 | $3,079 | $3,021 | $3,294 |
| % Growth | -9.2% | 1.9% | -8.3% | – |
| Gross Profit | $1,311 | $1,464 | $1,462 | $1,583 |
| % Margin | 46.9% | 47.5% | 48.4% | 48.1% |
| EBITDA | -$42 | -$18 | -$107 | -$247 |
| % Margin | -1.5% | -0.6% | -3.5% | -7.5% |
| Net Income | -$349 | -$357 | -$437 | -$3,525 |
| % Margin | -12.5% | -11.6% | -14.5% | -107% |
| EPS Diluted | -0.016 | -0.016 | -0.02 | -0.17 |
| % Growth | 2.4% | 19.2% | 88.1% | – |
| Operating Cash Flow | -$34 | $32 | -$170 | -$91 |
| Capital Expenditures | -$8 | -$12 | -$3 | -$7 |
| Free Cash Flow | -$42 | $20 | -$173 | -$98 |